Decision and cost-effectiveness analyses of Herpes zoster vaccination in adults 50 years of age and older
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


Decision and cost-effectiveness analyses of Herpes zoster vaccination in adults 50 years of age and older

Filetype[PDF-589.77 KB]


  • English

  • Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov